Human T cells interacting with HNSCC-derived mesenchymal stromal cells acquire tissue-resident memory like properties.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
10 2020
Historique:
received: 15 01 2020
revised: 14 04 2020
pubmed: 23 5 2020
medline: 12 1 2021
entrez: 23 5 2020
Statut: ppublish

Résumé

Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen. Trm cells express the surface markers CD69, CD103, and the immune checkpoint molecule PD-1. Trm cells develop not only in the context of infections but also in tumors, where they can provide a line of defense as suggested by the positive correlation between the frequency of tumor-infiltrating Trm cells and patients' survival. Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands. However, the cell sources of these factors are largely unknown, especially in the context of tumors. Here, we show that head-neck squamous cell carcinoma (HNSCC) is enriched in CD4+ and CD8+ T cells with a Trm phenotype. Moreover, we show that mesenchymal stromal cells that accumulate in HNSCC are a source of survival factors and allow proper expression of Trm-typical markers in a VCAM1-dependent manner.

Identifiants

pubmed: 32441311
doi: 10.1002/eji.202048544
doi:

Substances chimiques

Interleukin-15 0
Interleukin-7 0
Receptors, Notch 0
Vascular Cell Adhesion Molecule-1 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1571-1579

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
Pays : International

Informations de copyright

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Mueller, S. N. and Mackay, L. K., Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 2016. 16(2): 79-89.
Mackay, L. K., Braun, A., Macleod, B. L., Collins, N., Tebartz, C., Bedoui, S., Carbone, F. R. et al., Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J. Immunol. 2015. 194(5): 2059-2063.
Kumar, B. V., Ma, W., Miron, M., Granot, T., Guyer, R. S., Carpenter, D. J., Senda, T. et al., Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 2017. 20(12): 2921-2934.
Molodtsov, A. and Turk, M. J., Tissue resident CD8 memory T cell responses in cancer and autoimmunity. Front. Immunol. 2018. 9: 2810.
Amsen, D., van Gisbergen, K. P. J. M., Hombrink, P. and van Lier, R. A. W., Tissue-resident memory T cells at the center of immunity to solid tumors. Nat. Immunol. 2018. 19(6): 538-546.
Mackay, L. K., Rahimpour, A., Ma, J. Z., Collins, N., Stock, A. T., Hafon, M. L., Vega-Ramos, J. et al., The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 2013. 14(12): 1294-301.
Zhang, N. and Bevan, M J., Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity. 2013. 39(4): 687-696.
Prasad, S., Hu, S., Sheng, W. S., Chauhan, P., Singh, A. and Lokensgard, J. R., The PD-1: PD-L1 pathway promotes development of brain-resident memory T cells following acute viral encephalitis. J Neuroinflammation. 2017. 14(1): 82.
Adachi, T., Kobayashi, T., Sugihara, E., Yamada, T., Ikuta, K., Pittaluga, S., Saya, H. et al., Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat. Med. 2015. 21(11): 1272-1279.
Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E., Stark, R., Brasser, G. et al., Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nat. Immunol. 2016. 17(12): 1467-1478.
Schenkel, J. M., Fraser, K. A., Casey, K. A., Beura, L. K., Pauken, K. E., Vezys, V. and Masopust, D., IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. J. Immunol. 2016. 196(9): 3920-3926.
Özen, S. A., Sibel, D., Schulz, D., McGrath, M., Grün, J. R., Bardua, M., Ikuta, K. et al., Memory CD8(+) T cells colocalize with IL-7(+) stromal cells in bone marrow and rest in terms of proliferation and transcription. Eur. J. Immunol. 2015. 45(4): 975-987.
Liotta, F., Querci, V., Mannelli, G., Santarlasci, V., Maggi, L., Capone, M., Rossi, M. C. et al., Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation. Br. J. Cancer. 2015. 112(4): 745-754.
Sowell, R. T., Rogozinska, M., Nelson, C. E., Vezys, V. and Marzo, A. L., Cutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTOR. J. Immunol. 2014. 193(5): 2067-2071.
Thome, J. J., Yudanin, N., Ohmura, Y., Kubota, M., Grinshpun, B., Sathaliyawala, T., Kato, T. et al., Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell. 2014. 159(4): 814-828.
Maggi, L., Margheri, F., Luciani, C., Capone, M., Rossi, M. C., Chillà, A., Santarlasci, V. et al., Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients. PLoS One. 2016. 11(4): e0154422.
Garton, K. J., Gough, P. J., Philalay, J., Wille, P. T., Blobel, C. P., Whitehead, R. H., Dempsey, P. J. et al., Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J. Biol. Chem. 2003. 278(39): 37459-37464.
Stonier, S. W. and Schluns, K. S., Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 2010. 127(2): 85-92.
Weiss, A. R. R. and Dahlke, M H., Immunomodulation by mesenchymal stem cells (MSCs): Mechanisms of action of living, apoptotic, and dead MSCs. Front. Immunol. 2019. 10: 1191.
Djenidi, F., Adam, J., Goubar, A., Durgeau, A., Meurice, G., de Montpréville, V., Validire, P. et al., CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. J. Immunol. 2015. 194(7): 3475-3486.
Enamorado, M., Iborra, S., Priego, E., Cueto, F. J., Quintana, J. A., Martínez-Cano, S., Mejías-Pérez, E. et al., Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells. Nat. Commun. 2017. 8: 16073.
Cossarizza, A., Chang, H. D., Radbruch, A., Acs, A., Adam, D., Adam-Klages, S., Agace, W. W. et al., Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur. J. Immunol. 2019. 49(10): 1457-1973.
Mazzoni, A., Maggi, L., Siracusa, F., Ramazzotti, M., Rossi, M. C., Santarlasci, V., Montaini, G. et al., Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation. Eur. J. Immunol. 2019. 49(1): 79-95.
Van der Maaten, L. J. P. and Hinton, G. E., Visualizing high-dimensional data using t-SNE. J Mach Learn Res 2008. 9(Nov): 2579-2605.

Auteurs

Alessio Mazzoni (A)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.

Laura Maggi (L)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.

Gianni Montaini (G)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.

Matteo Ramazzotti (M)

Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Firenze, Italy.

Manuela Capone (M)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.

Anna Vanni (A)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.

Luca Giovanni Locatello (LG)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
SOD Otorinolaringoiatria, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Giusi Barra (G)

Institute of Biomolecular Chemistry, National Research Council (CNR), Naples, Italy.

Raffaele De Palma (R)

Institute of Biomolecular Chemistry, National Research Council (CNR), Naples, Italy.
Department of Internal Medicine, University of Genoa, Genoa, Italy.

Oreste Gallo (O)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
SOD Otorinolaringoiatria, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Lorenzo Cosmi (L)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
SOD Immunologia e Terapie Cellulari, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Francesco Liotta (F)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
SOD Immunologia e Terapie Cellulari, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
SOD Centro diagnostico di citofluorimetria e immunoterapia, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Francesco Annunziato (F)

Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
SOD Centro diagnostico di citofluorimetria e immunoterapia, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH